Loss Despite Sales Growth

Mckesson Corporation announced earnings per share of $-4.15 and Sales of $56.21 billions in the forth quarter 2019, Company's lost money per share, versus $-5.59 eps, earned in the same quarter a year ago, although Mckesson Corporation saw it's Sales rise by 1.55 % in the same period.

In comparison to previous quarter eps fell from $2.40 per share and Sales decreased by -6.72 % from $56.21 billions.
Mckesson Corporation said it's sales growth was driven by U.S. Healthcare direct distribution or services segment up 15.52% Pharmaceutical Solutions segment up 9.44% Medical-Surgical Solutions segment up 2.81%, while sales in Canada distribution or services segment fell -19.78%.
In the forth quarter 2019 Mckesson Corporation reported net loss of $-744 million, instead of deficit of $-1,085 millions in the same quarter a year ago.Mckesson Corporation cut it's annual earnings per share forecast by $ -2.24, now company expects eps from $9.96 to $10.46.
Looking into financial results for the fiscal year 2019, Mckesson Corporation reported Sales of $214.32 billions and net income of $255 millions.

Pharmacy Services & Retail Drugstore Company explained also, that Income per share faded by -46.88 % to $0.17 per share from $0.32 in the previous fiscal year, while Sales increased by 2.86 % from $208.36 billions a year ago.

Mckesson Corporation is expected to report next financial results on July 29, 2019.